Breaking News Instant updates and real-time market news.

TODAY'S FREE FLY STORIES

Hot Stocks
Foresight Autonomous receives two orders from Elbit Systems » 08:15
07/02/20
07/02
08:15
07/02/20
08:15
FRSX

Foresight Autonomous

$1.53 /

-0.04 (-2.55%)

, ESLT

Elbit Systems

$138.02 /

+2.02 (+1.49%)

Foresight Autonomous…

Foresight Autonomous (FRSX) announced that it has received two orders for product development and customization from Elbit Systems Land Ltd., a subsidiary of Elbit Systems (ESLT). Foresight said in a release, "Elbit Systems is Foresight's first commercial customer. Foresight will supply a QuadSight prototype system with wide-angle field-of-view detection capabilities designed to meet Elbit's requirements. Revenue from both orders is expected to total tens of thousands of dollars. Elbit placed the orders for product development and customization following thorough testing and evaluation of a QuadSight prototype system. Foresight's ability to make technological modifications to its system according to customer requirements allows the Company to provide tailor-made solutions that may be suitable for different markets. These orders are part of the commercial agreement that was signed with Elbit Systems, as reported by the Company on June 19th, 2019. The modified version of the QuadSight prototype including wide-angle field-of-view detection capabilities enhances on-road and off-road driving and enables the system to scan wider areas and detect more objects in the road ahead. These capabilities allow the decision-making system of the autonomous vehicle to make more accurate real-time decisions. This technological modification of the QuadSight prototype may also address the needs of different market segments, such as heavy-equipment vehicles, trucks and passenger cars."

ShowHide Related Items >><<
FRSX Foresight Autonomous
$1.53 /

-0.04 (-2.55%)

ESLT Elbit Systems
$138.02 /

+2.02 (+1.49%)

FRSX Foresight Autonomous
$1.53 /

-0.04 (-2.55%)

05/19/20 Alliance Global Partners
Foresight Autonomous initiated with a Buy at Alliance Global Partners
ESLT Elbit Systems
$138.02 /

+2.02 (+1.49%)

01/27/20 Jefferies
Jefferies starts Elbit Systems at Buy with $185 price target
01/27/20 Jefferies
Elbit Systems initiated with a Buy at Jefferies
09/19/19 Alliance Global Partners
RADA price target raised to $7.50 from $6.50 at Alliance Global Partners
07/25/19 Standpoint Research
Elbit Systems downgraded to Hold from Buy at Standpoint Research
General news
Jobless Claims to be reported at 08:30 » 08:15
07/02/20
07/02
08:15
07/02/20
08:15

Week of 6/27 Jobless…

Week of 6/27 Jobless Claims will be reported at 08:30 . Current consensus is 1,400K

General news
Employment Situation Nonfarm Payrolls to be reported at 08:30 » 08:15
07/02/20
07/02
08:15
07/02/20
08:15

June Employment Situation…

June Employment Situation Nonfarm Payrolls will be reported at 08:30 . Current consensus is 2,900,000 for the month

General news
International Trade Balance Level to be reported at 08:30 » 08:15
07/02/20
07/02
08:15
07/02/20
08:15

May International Trade…

May International Trade Balance Level will be reported at 08:30 . Current consensus is $[53.0]B

General news
Employment Situation Unemployment Rate to be reported at 08:30 » 08:15
07/02/20
07/02
08:15
07/02/20
08:15

June Employment Situation…

June Employment Situation Unemployment Rate will be reported at 08:30 . Current consensus is 12.3%

Recommendations
FedEx price target raised to $150 from $128 at Deutsche Bank » 08:14
07/02/20
07/02
08:14
07/02/20
08:14
FDX

FedEx

$156.86 /

+16.61 (+11.84%)

Deutsche Bank analyst…

Deutsche Bank analyst Amit Mehrotra raised the firm's price target on FedEx to $150 from $128 and keeps a Hold rating on the shares. The most surprising aspect of FedEx's better than expected results was a sequential step-up in margins at Ground, Mehrotra tells investors in a research note.

ShowHide Related Items >><<
FDX FedEx
$156.86 /

+16.61 (+11.84%)

FDX FedEx
$156.86 /

+16.61 (+11.84%)

07/01/20
Fly Intel: Top five analyst upgrades
07/01/20 Cowen
FedEx price target raised to $167 from $156 at Cowen
07/01/20 Wells Fargo
FedEx price target raised to $179 from $153 at Wells Fargo
07/01/20 Baird
FedEx price target raised to $162 from $140 at Baird
FDX FedEx
$156.86 /

+16.61 (+11.84%)

FDX FedEx
$156.86 /

+16.61 (+11.84%)

FDX FedEx
$156.86 /

+16.61 (+11.84%)

FDX FedEx
$156.86 /

+16.61 (+11.84%)

FDX FedEx
$156.86 /

+16.61 (+11.84%)

Recommendations
General Mills price target raised to $66 from $63 at BMO Capital » 08:14
07/02/20
07/02
08:14
07/02/20
08:14
GIS

General Mills

$60.43 /

-1.205 (-1.96%)

BMO Capital analyst…

BMO Capital analyst Kenneth Zaslow raised the firm's price target on General Mills to $66 from $63 and keeps a Market Perform rating on the shares. The company's Q4 earnings topped consensus due to a favorable operating leverage, lower merchandising costs, and lower taxes, which "more than offset" increased operating costs, though its lack of guidance for FY21 on heightened macro uncertainty implies some potential downside earnings risk, the analyst tells investors in a research note.

ShowHide Related Items >><<
GIS General Mills
$60.43 /

-1.205 (-1.96%)

GIS General Mills
$60.43 /

-1.205 (-1.96%)

06/29/20 Jefferies
Jefferies staying sidelined on General Mills ahead of earnings
06/11/20 Bernstein
General Mills downgraded to Underperform from Market Perform at Bernstein
05/21/20 Jefferies
General Mills price target raised to $61 from $56 at Jefferies
05/19/20 Piper Sandler
General Mills price target raised to $71 from $67 at Piper Sandler
GIS General Mills
$60.43 /

-1.205 (-1.96%)

GIS General Mills
$60.43 /

-1.205 (-1.96%)

GIS General Mills
$60.43 /

-1.205 (-1.96%)

GIS General Mills
$60.43 /

-1.205 (-1.96%)

Initiation
WillScot resumed with a Buy at Deutsche Bank » 08:12
07/02/20
07/02
08:12
07/02/20
08:12
WSC

WillScot

$13.12 /

+0.83 (+6.75%)

Deutsche Bank analyst…

Deutsche Bank analyst Ashish Sabadra resumed coverage of WillScot with a Buy rating and $16 price target following the close of the Mobile Mini merger. The analyst believes the company remains well positioned to benefit from the transaction given the "significant cross-sell opportunity" and $50M of cost synergies.

ShowHide Related Items >><<
WSC WillScot
$13.12 /

+0.83 (+6.75%)

WSC WillScot
$13.12 /

+0.83 (+6.75%)

07/01/20
Fly Intel: Top five analyst initiations
06/30/20 Stifel
WillScot initiated with a Buy at Stifel
05/28/20 BofA
WillScot resumed with a Buy at BofA
11/25/19 DA Davidson
WillScot price target raised to $23 from $20 at DA Davidson
WSC WillScot
$13.12 /

+0.83 (+6.75%)

Hot Stocks
Iqvia collaborates with LMC Manna Research to launch prime site in Canada » 08:12
07/02/20
07/02
08:12
07/02/20
08:12
IQV

Iqvia

$141.64 /

-0.44 (-0.31%)

Iqvia announced its…

Iqvia announced its strategic alliance with LMC Manna Research to launch Iqvia's first prime site in Canada. This adds to its network of more than 980 prime and partner clinical sites globally, which are sites with special designation assuring pharmaceutical and biotech companies their clinical trials will take place in investigative research centers with professionals and with infrastructure focused on research development for patients. LMC Manna and Iqvia will collaborate on research programs with goals to optimize processes, reduce the time to start clinical research, align procedures and support an increase in clinical and real-world evidence studies in Canada.

ShowHide Related Items >><<
IQV Iqvia
$141.64 /

-0.44 (-0.31%)

IQV Iqvia
$141.64 /

-0.44 (-0.31%)

04/29/20 Wells Fargo
Iqvia price target raised to $150 from $140 at Wells Fargo
04/29/20 Citi
Iqvia price target raised to $160 from $155 at Citi
04/28/20 Piper Sandler
Iqvia price target raised to $138 from $115 at Piper Sandler
04/08/20 Piper Sandler
Iqvia price target lowered to $115 from $163 at Piper Sandler
IQV Iqvia
$141.64 /

-0.44 (-0.31%)

  • 09
    Aug
IQV Iqvia
$141.64 /

-0.44 (-0.31%)

Recommendations
Capri Holdings price target raised to $25 from $21 at Deutsche Bank » 08:11
07/02/20
07/02
08:11
07/02/20
08:11
CPRI

Capri Holdings

$15.34 /

-0.305 (-1.95%)

Deutsche Bank analyst…

Deutsche Bank analyst Paul Trussell raised the firm's price target on Capri Holdings to $25 from $21 and keeps a Hold rating on the shares. The company's Q4 results and management commentary were ahead of expectations, including gross margin expansion at the two largest brands, the general quantification of digital trends and profitability, and an outline of expected sales recovery throughout fiscal 2021, Trussell tells investors in a research note. The analyst, however, remains on the sidelines "until there is greater visibility on the consumer's willingness to meaningfully re-engage with the overall category."

ShowHide Related Items >><<
CPRI Capri Holdings
$15.34 /

-0.305 (-1.95%)

CPRI Capri Holdings
$15.34 /

-0.305 (-1.95%)

07/02/20 UBS
Capri Holdings price target lowered to $26 from $37 at UBS
06/29/20 MKM Partners
Capri Holdings price target lowered to $15 from $35 at MKM Partners
06/08/20 Deutsche Bank
Capri Holdings price target lowered to $21 from $24 at Deutsche Bank
05/22/20 Jefferies
Jefferies adds six names to Franchise Picks list, including BioMarin and TJX
CPRI Capri Holdings
$15.34 /

-0.305 (-1.95%)

CPRI Capri Holdings
$15.34 /

-0.305 (-1.95%)

CPRI Capri Holdings
$15.34 /

-0.305 (-1.95%)

Hot Stocks
Exxon Mobil renews collaboration with Princeton Energy Center » 08:11
07/02/20
07/02
08:11
07/02/20
08:11
XOM

Exxon Mobil

$43.71 /

-0.98 (-2.19%)

ExxonMobil and Princeton…

ExxonMobil and Princeton University's Andlinger Center for Energy and the Environment have renewed their collaboration to research lower-emission technologies and energy solutions. ExxonMobil said in a release, "The new, five-year agreement builds on ExxonMobil's participation in Princeton's E-filliates Partnership, which began in 2015. E-filliates is a corporate membership program administered by the Andlinger Center and aims to help accelerate research, development and deployment of energy and environmental technologies through academia and industry partnerships. ExxonMobil is the world-leader in carbon capture, sequestering more carbon in the last 20 years than any other company. Princeton University is advancing this technology with new research to better understand how stored CO2 flows within rocks and interacts with minerals, improving the understanding of underground storage capacity. Future CO2 storage projects can be more optimally planned and operated to achieve net emissions reductions."

ShowHide Related Items >><<
XOM Exxon Mobil
$43.71 /

-0.98 (-2.19%)

XOM Exxon Mobil
$43.71 /

-0.98 (-2.19%)

06/09/20 Standpoint Research
Exxon Mobil downgraded to Hold from Buy at Standpoint Research
06/09/20 JPMorgan
Exxon Mobil price target raised to $51 from $44 at JPMorgan
05/13/20 Redburn
Exxon Mobil upgraded to Neutral from Sell at Redburn
05/04/20 Credit Suisse
Exxon Mobil price target raised to $45 from $37 at Credit Suisse
XOM Exxon Mobil
$43.71 /

-0.98 (-2.19%)

XOM Exxon Mobil
$43.71 /

-0.98 (-2.19%)

XOM Exxon Mobil
$43.71 /

-0.98 (-2.19%)

XOM Exxon Mobil
$43.71 /

-0.98 (-2.19%)

Hot Stocks
HF Foods Group appoints Russell Libby to board of directors » 08:10
07/02/20
07/02
08:10
07/02/20
08:10
HFFG

HF Foods Group

$8.88 /

-0.14 (-1.55%)

HF Foods Group welcomes…

HF Foods Group welcomes Russell Libby to the Company's board of directors effective July 1, 2020. Pursuant to the previous 8K filing and announcement dated March 23, 2020, Libby has replaced the outgoing director, Zhehui Ni, who resigned effective June 30, 2020 due to personal and professional obligations. As a result of the change, the Company's board of directors remained composed of five directors, including three independent directors and two inside directors. From 2007 to 2019, Libby held numerous leadership positions at Sysco Corp. and most recently served as the company's executive vice president and corporate secretary.

ShowHide Related Items >><<
HFFG HF Foods Group
$8.88 /

-0.14 (-1.55%)

HFFG HF Foods Group
$8.88 /

-0.14 (-1.55%)

Recommendations
Constellation Brands price target raised to $185 from $176 at Deutsche Bank » 08:09
07/02/20
07/02
08:09
07/02/20
08:09
STZ

Constellation Brands

$185.60 /

+11.17 (+6.40%)

Deutsche Bank analyst…

Deutsche Bank analyst Steve Powers raised the firm's price target on Constellation Brands to $185 from $176 and keeps a Hold rating on the shares following the company's Q2 results. The analyst shares Constellation's "cautious optimism" for underlying demand sustainability, improving shipment trends in beer, and progress in underlying free cash flow generation.

ShowHide Related Items >><<
STZ Constellation Brands
$185.60 /

+11.17 (+6.40%)

STZ Constellation Brands
$185.60 /

+11.17 (+6.40%)

07/02/20 UBS
Constellation Brands price target raised to $208 from $192 at UBS
07/02/20 Jefferies
Constellation Brands price target raised to $238 from $224 at Jefferies
07/02/20 Citi
Constellation Brands price target raised to $200 from $176 at Citi
07/02/20 HSBC
Constellation Brands price target raised to $170 from $147 at HSBC
STZ Constellation Brands
$185.60 /

+11.17 (+6.40%)

STZ Constellation Brands
$185.60 /

+11.17 (+6.40%)

STZ Constellation Brands
$185.60 /

+11.17 (+6.40%)

STZ Constellation Brands
$185.60 /

+11.17 (+6.40%)

Recommendations
BioNTech price target raised to $42 from $37 at SVB Leerink » 08:09
07/02/20
07/02
08:09
07/02/20
08:09
BNTX

BioNTech

$64.14 /

-2.595 (-3.89%)

, PFE

Pfizer

$33.74 /

+1.05 (+3.21%)

SVB Leerink analyst Daina…

SVB Leerink analyst Daina Graybosch raised the firm's price target on BioNTech (BNTX) to $42 from $37 and keeps a Market Perform rating on the shares. The analyst notes that the increase reflects an assumed increase in probability of technical and regulatory success after the company and partner Pfizer (PFE) reported immunogenicity data for 36 subjects vaccinated with BNT-162b1, a modRNA vaccine against the receptor-binding domain of the SARS-CoV-2 spike protein. Further, Graybosch also expects additional immunogenicity data in the coming weeks to be positive, which, likely, will result in more upside for BioNTech's stock.

ShowHide Related Items >><<
BNTX BioNTech
$64.14 /

-2.595 (-3.89%)

BNTX BioNTech
$64.14 /

-2.595 (-3.89%)

07/02/20 Bryan Garnier
BioNTech price target raised to $62.50 from $50 at Bryan Garnier
07/01/20 Goldman Sachs
Pfizer COVID-19 vaccine data 'encouraging,' says Goldman Sachs
06/30/20 H.C. Wainwright
BioNTech downgraded to Neutral from Buy at H.C. Wainwright
06/25/20 H.C. Wainwright
BioNTech price target lowered to $63 from $69 at H.C. Wainwright
PFE Pfizer
$33.74 /

+1.05 (+3.21%)

06/29/20 Mizuho
Pfizer resumed with a Buy at Mizuho
06/25/20 Piper Sandler
Aptevo Therapeutics price target raised to $24 from $18.50 at Piper Sandler
PFE Pfizer
$33.74 /

+1.05 (+3.21%)

BNTX BioNTech
$64.14 /

-2.595 (-3.89%)

  • 06
    Feb
  • 10
    Oct
PFE Pfizer
$33.74 /

+1.05 (+3.21%)

BNTX BioNTech
$64.14 /

-2.595 (-3.89%)

PFE Pfizer
$33.74 /

+1.05 (+3.21%)

BNTX BioNTech
$64.14 /

-2.595 (-3.89%)

PFE Pfizer
$33.74 /

+1.05 (+3.21%)

BNTX BioNTech
$64.14 /

-2.595 (-3.89%)

Hot Stocks
Credit Acceptance announces change of location of Annual Meeting of Shareholders » 08:09
07/02/20
07/02
08:09
07/02/20
08:09
CACC

Credit Acceptance

$420.69 /

+1.09 (+0.26%)

Credit Acceptance…

Credit Acceptance announced that, because of the continuing public health concerns relating to the COVID-19 pandemic, and in consideration of the health and well-being of shareholders and other meeting participants, the Company's annual meeting of shareholders to be held on Wednesday, July 15, 2020, at 8:00 a.m., Eastern time, will not be held at the Company's principal executive offices, but instead will be held solely by means of remote communication in a virtual meeting format by live audio webcast over the Internet. Shareholders will not be able to attend the Annual Meeting physically in person.

ShowHide Related Items >><<
CACC Credit Acceptance
$420.69 /

+1.09 (+0.26%)

CACC Credit Acceptance
$420.69 /

+1.09 (+0.26%)

06/03/20 Stephens
Stephens says Santander Consumer may benefit if Wells pulling back on auto loans
05/29/20 BMO Capital
Credit Acceptance price target raised to $337 from $316 at BMO Capital
04/06/20 BTIG
Credit Acceptance price target lowered to $160 from $190 at BTIG
03/19/20 BTIG
Credit Acceptance price target lowered to $190 from $340 at BTIG
CACC Credit Acceptance
$420.69 /

+1.09 (+0.26%)

CACC Credit Acceptance
$420.69 /

+1.09 (+0.26%)

Hot Stocks
Diversified Healthcare provides segment update amid COVID-19 pandemic » 08:09
07/02/20
07/02
08:09
07/02/20
08:09
DHC

Diversified Healthcare Trust

$4.45 /

+0.03 (+0.68%)

, FVE

Five Star Senior Living

$4.03 /

+0.115 (+2.94%)

The company said…

The company said Diversified Healthcare Trust's (DHT) office segment, which contains medical office and life science assets, has maintained strength through the pandemic. As of June 30, DHC had granted rent deferrals equal to $2.2M in its office segment, which represents only 0.6% of DHC's annualized total revenues. During Q2, DHC had collected approximately 99% of its office segment rents that were due in April, May and June, after giving effect to rent deferrals. In light of the pandemic, DHC has worked closely with its operator, Five Star Senior Living (FVE), to ensure that early measures were taken at DHC's senior living communities, including active engagement by Five Star with its employees who are responsible for implementing protocols from the Centers for Disease Control and Prevention and/or local-equivalent public health authorities and other best practices measures. As a result of these measures, DHC's SHOP segment has maintained occupancies that are generally consistent with its peers and slightly better than DHC's expectations. As of March 31, April 30 and May 31, occupancy in DHC's SHOP Segment was 81.6%, 79.5% and 78.2%%, respectively. As of June 30, occupancy in DHC's SHOP Segment was 77.4%.

ShowHide Related Items >><<
DHC Diversified Healthcare Trust
$4.45 /

+0.03 (+0.68%)

DHC Diversified Healthcare Trust
$4.45 /

+0.03 (+0.68%)

06/08/20 JMP Securities
Diversified Healthcare Trust resumed with a Market Perform at JMP Securities
05/19/20 RBC Capital
Diversified Healthcare Trust price target lowered to $3 from $7 at RBC Capital
03/11/20 Mizuho
Sabra Health Care to be pressured by coronavirus at facility, says Mizuho
01/16/20 Wells Fargo
Diversified Healthcare Trust cut to Equal Weight from Overweight at Wells Fargo
FVE Five Star Senior Living
$4.03 /

+0.115 (+2.94%)

10/14/19 BofA
Senior Housing resumed with an Underperform at BofA/Merrill
DHC Diversified Healthcare Trust
$4.45 /

+0.03 (+0.68%)

DHC Diversified Healthcare Trust
$4.45 /

+0.03 (+0.68%)

FVE Five Star Senior Living
$4.03 /

+0.115 (+2.94%)

DHC Diversified Healthcare Trust
$4.45 /

+0.03 (+0.68%)

Recommendations
Activision Blizzard price target raised to $90 from $75 at Needham » 08:08
07/02/20
07/02
08:08
07/02/20
08:08
ATVI

Activision Blizzard

$78.06 /

+2.17 (+2.86%)

Needham analyst Laura…

Needham analyst Laura Martin raised the firm's price target on Activision Blizzard to $90 from $75 and keeps a Buy rating on the shares. The analyst cites the expansion of the company's total addressable market with live sports and cinemas going dark as well as higher revenues being generated by the COVID-19 lockdowns. Martin adds that eSports should become a "key upside driver" for Activision Blizzard as the company has launched its second pro league based on its Call of Duty game and as "parents understand" the social aspect of videogames during the shelter-in-place period.

ShowHide Related Items >><<
ATVI Activision Blizzard
$78.06 /

+2.17 (+2.86%)

ATVI Activision Blizzard
$78.06 /

+2.17 (+2.86%)

07/01/20 BofA
BofA makes 14 additions, four deletions from US 1 list
06/29/20 Benchmark
Activision Blizzard price target raised to $85 from $77 at Benchmark
06/15/20 Stephens
Electronic Arts seems like best fit as buyer for WB Interactive, says Stephens
06/15/20 Oppenheimer
EA makes 'most sense' as potential buyer of Warner gaming unit, says Oppenheimer
ATVI Activision Blizzard
$78.06 /

+2.17 (+2.86%)

ATVI Activision Blizzard
$78.06 /

+2.17 (+2.86%)

ATVI Activision Blizzard
$78.06 /

+2.17 (+2.86%)

ATVI Activision Blizzard
$78.06 /

+2.17 (+2.86%)

Hot Stocks
Post Holdings appoints Dorothy Burwell to board of directors » 08:08
07/02/20
07/02
08:08
07/02/20
08:08
POST

Post Holdings

$87.39 /

-0.1 (-0.11%)

Post Holdings announced…

Post Holdings announced Dorothy Burwell, Partner at The Finsbury Group has been appointed to its Board of Directors, effective July 1, 2020. With the addition of Ms. Burwell, the Board now consists of ten members. In 2008, she joined Finsbury, a global strategic communications consultancy part of WPP, and in 2015, she was promoted to Partner with a variety of responsibilities across client relationship management, company marketing and business development.

ShowHide Related Items >><<
POST Post Holdings
$87.39 /

-0.1 (-0.11%)

POST Post Holdings
$87.39 /

-0.1 (-0.11%)

06/22/20 Goldman Sachs
Post Holdings upgraded to Buy from Neutral at Goldman Sachs
05/04/20 Wells Fargo
Post Holdings price target lowered to $110 from $120 at Wells Fargo
04/09/20
Fly Intel: Top five analyst initiations
04/09/20 Citi
Post Holdings assumed with a Buy at Citi
POST Post Holdings
$87.39 /

-0.1 (-0.11%)

Syndicate
SunPower's planned spin-off, Maxeon Solar Technologies, files Form 20-F » 08:07
07/02/20
07/02
08:07
07/02/20
08:07
SPWR

SunPower

$7.64 /

-0.045 (-0.59%)

SunPower announced that…

SunPower announced that its planned spin-off, Maxeon Solar Technologies, filed an initial Form 20-F registration statement with the U.S. SEC. The form includes a detailed business overview with strategy, financials and competitive strengths relating to Maxeon Solar and the spin-off. SunPower anticipates closing the planned spin-off of Maxeon Solar during the third quarter. In May, Maxeon Solar's future investor and long-time partner Tianjin Zhonghuan Semiconductor Co. received necessary regulatory approval from the China State Administration for Market Regulation.

ShowHide Related Items >><<
SPWR SunPower
$7.64 /

-0.045 (-0.59%)

SPWR SunPower
$7.64 /

-0.045 (-0.59%)

06/02/20 Roth Capital
Roth says loan securitizations reopening a positive for residential solar names
05/28/20 JPMorgan
SunPower price target raised to $10 from $9 at JPMorgan
04/24/20 Morgan Stanley
Federal support for renewables could come in summer, says Morgan Stanley
04/03/20 Barclays
Barclays halves SunPower target to $2.50, sees risk of insolvency
SPWR SunPower
$7.64 /

-0.045 (-0.59%)

  • 21
    Nov
SPWR SunPower
$7.64 /

-0.045 (-0.59%)

SPWR SunPower
$7.64 /

-0.045 (-0.59%)

Hot Stocks
Tesla rallies after Q2 deliveries of 90,650 top 83,071 estimate  08:07
07/02/20
07/02
08:07
07/02/20
08:07
TSLA

Tesla

$1,118.00 /

+39 (+3.61%)

 
ShowHide Related Items >><<
TSLA Tesla
$1,118.00 /

+39 (+3.61%)

TSLA Tesla
$1,118.00 /

+39 (+3.61%)

07/02/20 Wedbush
Wedbush boosts Tesla target to $1,250 with new bull case of $2,000
07/01/20 Wedbush
'Impressive' trajectory in June bodes well for Tesla deliveries, says Wedbush
06/30/20 Oppenheimer
Oppenheimer anticipates in-line or ahead of consensus Q2 deliveries for Tesla
06/30/20 JMP Securities
Tesla price target raised to $1,050 from $1,001 at JMP Securities
TSLA Tesla
$1,118.00 /

+39 (+3.61%)

  • 14
    Feb
TSLA Tesla
$1,118.00 /

+39 (+3.61%)

TSLA Tesla
$1,118.00 /

+39 (+3.61%)

TSLA Tesla
$1,118.00 /

+39 (+3.61%)

TSLA Tesla
$1,118.00 /

+39 (+3.61%)

Hot Stocks
Tesla jumps 9% to $1,221.19 after Q2 deliveries top estimates  08:06
07/02/20
07/02
08:06
07/02/20
08:06
TSLA

Tesla

$1,118.00 /

+39 (+3.61%)

 
ShowHide Related Items >><<
TSLA Tesla
$1,118.00 /

+39 (+3.61%)

TSLA Tesla
$1,118.00 /

+39 (+3.61%)

07/02/20 Wedbush
Wedbush boosts Tesla target to $1,250 with new bull case of $2,000
07/01/20 Wedbush
'Impressive' trajectory in June bodes well for Tesla deliveries, says Wedbush
06/30/20 Oppenheimer
Oppenheimer anticipates in-line or ahead of consensus Q2 deliveries for Tesla
06/30/20 JMP Securities
Tesla price target raised to $1,050 from $1,001 at JMP Securities
TSLA Tesla
$1,118.00 /

+39 (+3.61%)

  • 14
    Feb
TSLA Tesla
$1,118.00 /

+39 (+3.61%)

TSLA Tesla
$1,118.00 /

+39 (+3.61%)

TSLA Tesla
$1,118.00 /

+39 (+3.61%)

TSLA Tesla
$1,118.00 /

+39 (+3.61%)

Hot Stocks
Kratos Defense receives $30M C5ISR contract awards » 08:06
07/02/20
07/02
08:06
07/02/20
08:06
KTOS

Kratos Defense

$15.33 /

-0.315 (-2.01%)

Kratos Defense &…

Kratos Defense & Security Solutions announced that it has recently received approximately $30M in contract awards for Command, Control, Computing, Communication, Combat, Intelligence, Surveillance and Reconnaissance Systems, focused primarily on missile defense related combat systems. Kratos is an industry leader in the rapid development, demonstration and fielding of affordable leading technology products and solutions in support of the United States and its allies' national security missions. Kratos C5ISR Modular Systems Business is an industry leader in manufacturing, producing and delivering C5ISR Systems for Missile, Radar, High Power Directed Energy, Ballistic Missile Defense, Unmanned Aerial Vehicle, Chemical, Biological, Radiation, Nuclear and High Explosive and other programs and applications. Work under these recent program awards will be performed at secure Kratos manufacturing and production facilities. The majority of the performance under these contract awards will be completed over the next 24 months. Due to customer, competitive and other considerations, no additional information will be provided related to these U.S. National Security related program awards.

ShowHide Related Items >><<
KTOS Kratos Defense
$15.33 /

-0.315 (-2.01%)

KTOS Kratos Defense
$15.33 /

-0.315 (-2.01%)

04/06/20 Canaccord
Kratos Defense acquisition provides long-term opportunity, says Canaccord
03/18/20 Benchmark
Benchmark starts Kratos Defense at Buy, sees 'commanding' lead in drones
03/18/20 Benchmark
Kratos Defense initiated with a Buy at Benchmark
03/11/20 SunTrust
Kratos Defense upgraded to Buy from Hold at SunTrust
KTOS Kratos Defense
$15.33 /

-0.315 (-2.01%)

  • 19
    Jun
KTOS Kratos Defense
$15.33 /

-0.315 (-2.01%)

Recommendations
PayPal price target raised to $200 from $176 at Wedbush » 08:05
07/02/20
07/02
08:05
07/02/20
08:05
PYPL

PayPal

$177.47 /

+3.29 (+1.89%)

Wedbush analyst Moshe…

Wedbush analyst Moshe Katri raised the firm's price target on PayPal to $200 from $176 and keeps an Outperform rating on the shares. The analyst believes 2020 and 2021's results will likely show accelerating revenue growth, reflecting more intensive/efficient monetization at Venmo. While prior monetization efforts targeted a consumer base of 52M accounts, a new feature will target SMBs, which he believes opens an entirely new merchants' universe for Paypal's eco-system, with incremental revenue opportunities from cross-selling, selling-fees, as well as advertising. PayPal is on the Wedbush Best Ideas List.

ShowHide Related Items >><<
PYPL PayPal
$177.47 /

+3.29 (+1.89%)

PYPL PayPal
$177.47 /

+3.29 (+1.89%)

06/30/20
Fly Intel: Top five analyst initiations
06/30/20 Canaccord
PayPal price target raised to $190 from $160 at Canaccord
06/30/20 Citi
PayPal remains a top idea at Citi
06/30/20 JMP Securities
PayPal initiated with an Outperform at JMP Securities
PYPL PayPal
$177.47 /

+3.29 (+1.89%)

PYPL PayPal
$177.47 /

+3.29 (+1.89%)

PYPL PayPal
$177.47 /

+3.29 (+1.89%)

PYPL PayPal
$177.47 /

+3.29 (+1.89%)

Hot Stocks
BNY Mellon announces collaboration with Early Warning Services » 08:05
07/02/20
07/02
08:05
07/02/20
08:05
BK

BNY Mellon

$37.57 /

-1.09 (-2.82%)

BNY Mellon announced a…

BNY Mellon announced a collaboration with risk and payments solution provider Early Warning Services. Through this agreement, BNY Mellon will deliver real-time account validation services to clients, and offer the flexibility to tailor a solution to meet clients' individual needs- whether through BNY Mellon directly, or through one of its Private Label Bank relationships.

ShowHide Related Items >><<
BK BNY Mellon
$37.57 /

-1.09 (-2.82%)

BK BNY Mellon
$37.57 /

-1.09 (-2.82%)

06/11/20 Deutsche Bank
BNY Mellon named short-term investment idea at Deutsche Bank
06/05/20 Wells Fargo
BNY Mellon price target raised to $47 from $40 at Wells Fargo
04/09/20 JPMorgan
BNY Mellon upgraded to Neutral with $41.50 price target at JPMorgan
04/09/20 JPMorgan
BNY Mellon upgraded to Neutral from Underweight at JPMorgan
BK BNY Mellon
$37.57 /

-1.09 (-2.82%)

BK BNY Mellon
$37.57 /

-1.09 (-2.82%)

BK BNY Mellon
$37.57 /

-1.09 (-2.82%)

BK BNY Mellon
$37.57 /

-1.09 (-2.82%)

Hot Stocks
Centogene receives EUA for COVID-19 molecular diagnostic test » 08:05
07/02/20
07/02
08:05
07/02/20
08:05
CNTG

Centogene

$25.20 /

+3.21 (+14.60%)

Centogene announced that…

Centogene announced that the U.S. Food and Drug Administration has issued Emergency Use Authorization (EUA) for the company's SARS-CoV-2 RT-PCR test.

ShowHide Related Items >><<
CNTG Centogene
$25.20 /

+3.21 (+14.60%)

CNTG Centogene
$25.20 /

+3.21 (+14.60%)

04/24/20 BTIG
Centogene price target raised to $23 from $18 at BTIG
04/24/20 Evercore ISI
Centogene downgraded to In Line from Outperform at Evercore ISI
12/03/19 Baird
Centogene initiated with an Outperform at Baird
12/02/19 BTIG
Centogene initiated with a Buy at BTIG
  • 07
    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.